Incidence of tardive dyskinesia in patients receiving depot neuroleptic injection.
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D004409:Dyskinesia, Drug-Induced / Q000453:epidemiology* / Q000503:physiopathology; D005260:Female; D005475:Flupenthixol / Q000009:adverse effects; D005476:Fluphenazine / Q000009:adverse effects; D005484:Fluspirilene / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D005484:Fluspirilene; D005475:Flupenthixol; D005476:Fluphenazine